Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Andrew McLachlan

Has grant

Professor of Pharmacy

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

About

Professor Andrew McLachlan is a faculty member at the University of Sydney, Australia. His research areas include pharmacotherapy, with a focus on clinical effectiveness and safety in oncology, pain management, and community pharmacy practices. His recent publications discuss topics such as neuropathic cancer pain treatment, medicine disposal interventions, and the impact of natural products on drug interactions. Committed to advancing pharmacy practice, he also explores conscientious objection in healthcare settings.

Recent Grants

Grant: Close

Patient-centred eHealth approach to improving outcomes for gout sufferers

Open Date: 2015-01-01

Close Date: 2020-01-01

Grant: Close

The first placebo-controlled trial of opioid analgesics for acute spinal pain

Open Date: 2015-01-01

Close Date: 2017-01-01

Grant: Close

Medicines and Ageing

Open Date: 2013-01-01

Close Date: 2018-01-01

Grant: Close

PRECISE: pregabalin in addition to usual care for sciatica

Open Date: 2013-01-01

Close Date: 2016-01-01

Grant: Close

A randomised controlled trial of deprescribing to optimise medical therapy for frail older people: the Opti-Med study.

Open Date: 2013-01-01

Close Date: 2016-01-01

Articles (47)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (55)

Christina Abdel Shaheed

AUSTRALIA

Andrew McLachlan

Research Interests

Explore related searches

About

Recent Grants

Articles (47)

Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0

SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain

Deprescribing in Older People

Effect of an oral complementary medicine combination for symptomatic knee osteoarthritis: A double-blind, randomized, placebo-controlled trial

Oral oxycodone versus sublingual buprenorphine for postoperative pain control after pelvic exenteration (PROSPER): a pilot, registry-embedded, multi-centre, double-blind, placebo-controlled, randomised controlled trial

Efficacy and Harms of Opioid Analgesics for Acute Pain: Overview of Systematic Reviews and Meta-analyses

Oxycodone/naloxone versus placebo for acute spinal pain in compliant participants: secondary analysis of a randomised clinical trial

Understanding Pharmacokinetic Variability of Pomalidomide: A Physiologically Based Pharmacokinetic Analysis of Disease-Related Physiology, Ethnicity, Hepatic Impairment, Food Effects, Drug Interactions, and Smoking

A Review of Lipid Management Following Acute Coronary Syndrome – A South Auckland Experience

413 EFFICACY AND SAFETY OF AN ORAL COMPLEMENTARY MEDICINE COMBINATION FOR SYMPTOMATIC KNEE OSTEOARTHRITIS (ATLAS): A RANDOMISED TRIAL

414 BENEFITS AND HARMS OF COMPLEMENTARY MEDICINE USE FOR OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED, PLACEBO-CONTROLLED TRIALS

WCN26-3667 PATIENT EXPERIENCES WITH CANNABIDIOL FOR SYMPTOM MANAGEMENT IN KIDNEY FAILURE: QUALITATIVE INSIGHTS FROM THE SEISMIC-CBD TRIAL

WCN26-5407 PHARMACOKINETICS OF CANNABIDIOL IN PEOPLE WITH KIDNEY FAILURE: FINDINGS FROM THE SEISMIC-CBD TRIAL

Urinary Δ9-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review

Pharmacokinetics of pazopanib: a review of the determinants, influencing factors and the clinical importance of therapeutic drug monitoring

A Phase 1B Trial of Cannabidiol for Symptom Management in Kidney Failure

Consumer purchasing behaviour: oral contraceptives with Hypericum perforatum, and atorvastatin with Camellia sinensis: an Australia-wide basket analysis

Lidocaine for Neuropathic Cancer Pain (LiCPain): A Pilot Randomized Controlled Trial

Capabilities, opportunities and motivations within Australian community pharmacy to deliver clinical standard-aligned care for knee osteoarthritis: A mixed-methods evaluation

Green Tea Catechins as Perpetrators of Drug Pharmacokinetic Interactions

Effectiveness of interventions designed to increase safe medicine disposal: a systematic review and meta-analysis of randomised trials

Inter‐Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials

Developing a framework for managing conscientious objection in healthcare - Australia

Prevalence of heart failure pharmacotherapy utilisation, frailty and adverse drug events among hospitalised adults older than 75 years: a multicentre cross‐sectional study

Adverse Drug Events Associated with Optimizing Heart Failure Pharmacotherapy in Older Adults with Frailty: A Qualitative Study

Pharmacokinetics and Bioavailability of Cannabinoids Administered via a Novel Orobuccal Nanoparticle Formulation (NanoCelle™) in Patients with Advanced Cancer

ANZACS-QI Heart Failure Registry—Improving Heart Failure Care in New Zealand

Conscientious objection – a cross-sectional, vignette-based, mixed methods exploration of Australian pharmacists’ perspectives

Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review

The effect of down‐titration and discontinuation of heart failure pharmacotherapy in older people: A systematic review and meta‐analysis

Efficacy and safety of antidepressants for pain in older adults: A systematic review and meta‐analysis

Policies and cost analyses of voluntary assisted dying (VAD) laws – a mapping review & analysis

Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses

Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

Opioid analgesics for nociceptive cancer pain: A comprehensive review

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews

Deprescribing interventions for gabapentinoids in adults: A scoping review

Conscientious objection – A vignette-based, pilot study of international pharmacists’ perspectives

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia

An evaluation of the quality of Annona muricata leaf products

Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis

Comparison of capecitabine concentrations determined by microsampling versus plasma concentrations for therapeutic drug monitoring: a pilot study

Editorial: National Medicines Policy 2.0—what’s changed and what’s next?

Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS‐CoV‐2 Infection: A Case Study With Imatinib

Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection

Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey

Collaborators (55)

Christina Abdel Shaheed

Jennifer H. Martin

Richard O. Day

Alan Boddy

Chung-Wei Christine Lin

Matthew Jones

Bart Koes

Danijela Gnjidic

Christopher Irwin

Tin Fei Sim

Andrew Stafford

Antony Clark

Martin Underwood

Fiona Stanaway

Rienk Nieuwland

Marguerite Tracy

Tony Lai

Amy Page

Priyanka Vandersman

Jennifer Hunter

Matthew Bagg

Betty B. Chaar

Kim Bennell

Nilufeur McKay

Stephanie Mathieson

Allison McKendrick